Alnylam Pharmaceuticals, Inc.

PNC FINANCIAL SERVICES GROUP, INC. ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/6/2026

Shares

12,678

Value ($000)

5,041

Weight

0.0%

2014 Q1 - 2025 Q4 (27 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/6/2026	5,041	0.0%	12,678	12/31/2025
2025 Q3	11/7/2025	5,981	0.0%	13,115	9/30/2025
2025 Q2	8/8/2025	4,295	0.0%	13,170	6/30/2025
2025 Q1	5/9/2025	3,544	0.0%	13,125	3/31/2025
2024 Q4	2/7/2025	2,951	0.0%	12,540	12/31/2024
2024 Q3	11/8/2024	3,450	0.0%	12,543	9/30/2024
2024 Q2	8/9/2024	3,013	0.0%	12,399	6/30/2024
2024 Q1	5/10/2024	1,821	0.0%	12,187	3/31/2024
2023 Q4	3/22/2024	2,511	0.0%	13,118	12/31/2023
2023 Q3	11/13/2023	2,774	0.0%	15,665	9/30/2023
2023 Q2	8/11/2023	2,983	0.0%	15,704	6/30/2023
2023 Q1	5/15/2023	3,127	0.0%	15,608	3/31/2023
2022 Q4	2/10/2023	3,703	0.0%	15,583	12/31/2022
2022 Q3	11/10/2022	3,162	0.0%	15,797	9/30/2022
2022 Q2	8/12/2022	2,386	0.0%	16,356	6/30/2022
2022 Q1	5/12/2022	2,533	0.0%	15,510	3/31/2022
2021 Q4	2/11/2022	2,630	0.0%	15,509	12/31/2021
2021 Q3	11/5/2021	2,926	0.0%	15,503	9/30/2021
2021 Q2	8/6/2021	2,712	0.0%	16,002	6/30/2021
2021 Q1	5/7/2021	2,245	0.0%	15,895	3/31/2021
2020 Q4	2/12/2021	1,871	0.0%	14,391	12/31/2020
2020 Q3	11/6/2020	883	0.0%	6,070	9/30/2020
2020 Q2	8/28/2020	1,013	0.0%	6,849	6/30/2020
2020 Q1	5/8/2020	1,445	0.0%	13,282	3/31/2020
2019 Q4	2/7/2020	1,040	0.0%	9,020	12/31/2019
2014 Q2	8/8/2014	11	0.0%	177	6/30/2014
2014 Q1	5/9/2014	12	0.0%	177	3/31/2014